Acquisition highlights of Ahammune Biosciences and a snapshot of its key metrics.

Founded in 2016, Ahammune Biosciences operates in the biotechnology sector, focusing on the development of novel therapies for skin disorders. Initially concentrating on therapeutic solutions for vitiligo, the company has expanded its research and development efforts to include treatments for other dermatological conditions. The companys offerings have broadened through collaborations with leading research institutions, enhancing their scientific capabilities in dermatological innovations. Competing with companies such as Vyome Therapeutics and Invictus Oncology.

Parul Ganju

Dr Krishnamurthy Natarajan

Founded in 2016, Ahammune Biosciences has raised 5.00 Mn+ in funding from a total number of 16 investors.

Ahammune Biosciences – Total Funding, Funding Over Time, Funding By Rounds and More.

Funding highlights of Ahammune Biosciences and a snapshot of its key metrics.

Dr.Ajith Kamath

Capital 2B

Ideaspring Capital

Pi Ventures

Indian Angel Network

Legacy asset

Kotak Investment Advisors

Kotak Private Equity

Suman Kant Munjal

Dr. Ganesh Natarajan

Anand Deshpande

Unicornus Maximus

Bipin Agarwal

Colossa Ventures

Investment highlights of Ahammune Biosciences and a snapshot of its key metrics.

Ahammune Biosciences - A Health Tech Funded Company Based Out Of Pune

Ahammune Biosciences

A snapshot of highlights, scale, and metrics

An overview of key people in Ahammune Biosciences.

A Health Tech Funded Company Based Out Of Pune

Ahammune Biosciences - Financials, Revenue, P&L Statement, Balance Sheet, Cash Flow & More